Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DPR000117

Drug Information
NameUCL-2000 and butabindide
CompanyUniversity College London
[ICD9: 278   ICD10: E66]
Phase I    
CAS NumberCAS 185213-03-0
TargetCholecystokinin type A receptorAgonist[1]
Cholecystokinin type A receptorMultitarget[1]
Tripeptidyl-peptidase 2 Inhibitor[1]
Tripeptidyl-peptidase 2 Multitarget[1]
Ref 1Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543